Higher serum uric acid associated with decreased Parkinson's disease prevalence in a large community‐based survey
Identifieur interne : 002639 ( Main/Corpus ); précédent : 002638; suivant : 002640Higher serum uric acid associated with decreased Parkinson's disease prevalence in a large community‐based survey
Auteurs : Andrea Winquist ; Kyle Steenland ; Anoop ShankarSource :
- Movement Disorders [ 0885-3185 ] ; 2010-05-15.
English descriptors
Abstract
A large community‐based cross‐sectional survey provided an opportunity to evaluate a previously reported association between Parkinson's disease (PD) and low serum uric acid (UA) levels in this population. The association between a self‐reported PD diagnosis with treatment (n = 59) and serum UA level was examined using logistic and linear regression models, controlling for key covariates. In adjusted models, participants with UA levels at or above the median had a significantly lower odds of reporting PD with treatment compared with those with lower UA levels (OR 0.33, 95% CI 0.19–0.60, P = 0.0002). This association was observed for both men and women. The mean UA level among participants reporting PD with treatment was 0.78 mg/dl lower than the mean UA level among those not reporting PD (P ≤ 0.0001). These findings concur with several previous longitudinal studies that found an association between higher UA levels and decreased PD risk. © 2010 Movement Disorder Society
Url:
DOI: 10.1002/mds.23070
Links to Exploration step
ISTEX:65FE60C80A7EB6F121035CB743F3C053D84C4910Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Higher serum uric acid associated with decreased Parkinson's disease prevalence in a large community‐based survey</title><author><name sortKey="Winquist, Andrea" sort="Winquist, Andrea" uniqKey="Winquist A" first="Andrea" last="Winquist">Andrea Winquist</name><affiliation><mods:affiliation>Department of Environmental and Occupational Health, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA</mods:affiliation></affiliation></author><author><name sortKey="Steenland, Kyle" sort="Steenland, Kyle" uniqKey="Steenland K" first="Kyle" last="Steenland">Kyle Steenland</name><affiliation><mods:affiliation>Department of Environmental and Occupational Health, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA</mods:affiliation></affiliation></author><author><name sortKey="Shankar, Anoop" sort="Shankar, Anoop" uniqKey="Shankar A" first="Anoop" last="Shankar">Anoop Shankar</name><affiliation><mods:affiliation>Department of Community Medicine, West Virginia University School of Medicine, Morgantown, West Virginia, USA</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:65FE60C80A7EB6F121035CB743F3C053D84C4910</idno><date when="2010" year="2010">2010</date><idno type="doi">10.1002/mds.23070</idno><idno type="url">https://api.istex.fr/document/65FE60C80A7EB6F121035CB743F3C053D84C4910/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">002639</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Higher serum uric acid associated with decreased Parkinson's disease prevalence in a large community‐based survey</title><author><name sortKey="Winquist, Andrea" sort="Winquist, Andrea" uniqKey="Winquist A" first="Andrea" last="Winquist">Andrea Winquist</name><affiliation><mods:affiliation>Department of Environmental and Occupational Health, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA</mods:affiliation></affiliation></author><author><name sortKey="Steenland, Kyle" sort="Steenland, Kyle" uniqKey="Steenland K" first="Kyle" last="Steenland">Kyle Steenland</name><affiliation><mods:affiliation>Department of Environmental and Occupational Health, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA</mods:affiliation></affiliation></author><author><name sortKey="Shankar, Anoop" sort="Shankar, Anoop" uniqKey="Shankar A" first="Anoop" last="Shankar">Anoop Shankar</name><affiliation><mods:affiliation>Department of Community Medicine, West Virginia University School of Medicine, Morgantown, West Virginia, USA</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2010-05-15">2010-05-15</date><biblScope unit="volume">25</biblScope><biblScope unit="issue">7</biblScope><biblScope unit="page" from="932">932</biblScope><biblScope unit="page" to="936">936</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">65FE60C80A7EB6F121035CB743F3C053D84C4910</idno><idno type="DOI">10.1002/mds.23070</idno><idno type="ArticleID">MDS23070</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Parkinson's disease</term><term>cross‐sectional survey</term><term>uric acid</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">A large community‐based cross‐sectional survey provided an opportunity to evaluate a previously reported association between Parkinson's disease (PD) and low serum uric acid (UA) levels in this population. The association between a self‐reported PD diagnosis with treatment (n = 59) and serum UA level was examined using logistic and linear regression models, controlling for key covariates. In adjusted models, participants with UA levels at or above the median had a significantly lower odds of reporting PD with treatment compared with those with lower UA levels (OR 0.33, 95% CI 0.19–0.60, P = 0.0002). This association was observed for both men and women. The mean UA level among participants reporting PD with treatment was 0.78 mg/dl lower than the mean UA level among those not reporting PD (P ≤ 0.0001). These findings concur with several previous longitudinal studies that found an association between higher UA levels and decreased PD risk. © 2010 Movement Disorder Society</div></front></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>Andrea Winquist MD, PhD</name><affiliations><json:string>Department of Environmental and Occupational Health, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA</json:string></affiliations></json:item><json:item><name>Kyle Steenland PhD</name><affiliations><json:string>Department of Environmental and Occupational Health, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA</json:string></affiliations></json:item><json:item><name>Anoop Shankar MD, PhD</name><affiliations><json:string>Department of Community Medicine, West Virginia University School of Medicine, Morgantown, West Virginia, USA</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>uric acid</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Parkinson's disease</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>cross‐sectional survey</value></json:item></subject><articleId><json:string>MDS23070</json:string></articleId><language><json:string>eng</json:string></language><abstract>A large community‐based cross‐sectional survey provided an opportunity to evaluate a previously reported association between Parkinson's disease (PD) and low serum uric acid (UA) levels in this population. The association between a self‐reported PD diagnosis with treatment (n = 59) and serum UA level was examined using logistic and linear regression models, controlling for key covariates. In adjusted models, participants with UA levels at or above the median had a significantly lower odds of reporting PD with treatment compared with those with lower UA levels (OR 0.33, 95% CI 0.19–0.60, P = 0.0002). This association was observed for both men and women. The mean UA level among participants reporting PD with treatment was 0.78 mg/dl lower than the mean UA level among those not reporting PD (P ≤ 0.0001). These findings concur with several previous longitudinal studies that found an association between higher UA levels and decreased PD risk. © 2010 Movement Disorder Society</abstract><qualityIndicators><score>6.848</score><pdfVersion>1.3</pdfVersion><pdfPageSize>612 x 810 pts</pdfPageSize><refBibsNative>true</refBibsNative><keywordCount>3</keywordCount><abstractCharCount>984</abstractCharCount><pdfWordCount>14263</pdfWordCount><pdfCharCount>95853</pdfCharCount><pdfPageCount>26</pdfPageCount><abstractWordCount>154</abstractWordCount></qualityIndicators><title>Higher serum uric acid associated with decreased Parkinson's disease prevalence in a large community‐based survey</title><genre><json:string>article</json:string></genre><host><volume>25</volume><publisherId><json:string>MDS</json:string></publisherId><pages><total>5</total><last>936</last><first>932</first></pages><issn><json:string>0885-3185</json:string></issn><issue>7</issue><subject><json:item><value>Brief Report</value></json:item></subject><genre><json:string>Journal</json:string></genre><language><json:string>unknown</json:string></language><eissn><json:string>1531-8257</json:string></eissn><title>Movement Disorders</title><doi><json:string>10.1002/(ISSN)1531-8257</json:string></doi></host><publicationDate>2010</publicationDate><copyrightDate>2010</copyrightDate><doi><json:string>10.1002/mds.23070</json:string></doi><id>65FE60C80A7EB6F121035CB743F3C053D84C4910</id><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/65FE60C80A7EB6F121035CB743F3C053D84C4910/fulltext/pdf</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/65FE60C80A7EB6F121035CB743F3C053D84C4910/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/65FE60C80A7EB6F121035CB743F3C053D84C4910/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Higher serum uric acid associated with decreased Parkinson's disease prevalence in a large community‐based survey</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><availability><p>WILEY</p></availability><date>2010</date></publicationStmt><notesStmt><note type="content">*Potential conflict of interest: None reported.</note><note>C8 Class Action Settlement Agreement (Circuit Court of Wood County, West Virginia)</note></notesStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Higher serum uric acid associated with decreased Parkinson's disease prevalence in a large community‐based survey</title><author><persName><forename type="first">Andrea</forename><surname>Winquist</surname></persName><roleName type="degree">MD, PhD</roleName><note type="correspondence"><p>Correspondence: Rollins School of Public Health, 1518 Clifton Road NE, Room 214, Atlanta, GA 30322</p></note><affiliation>Department of Environmental and Occupational Health, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA</affiliation></author><author><persName><forename type="first">Kyle</forename><surname>Steenland</surname></persName><roleName type="degree">PhD</roleName><affiliation>Department of Environmental and Occupational Health, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA</affiliation></author><author><persName><forename type="first">Anoop</forename><surname>Shankar</surname></persName><roleName type="degree">MD, PhD</roleName><affiliation>Department of Community Medicine, West Virginia University School of Medicine, Morgantown, West Virginia, USA</affiliation></author></analytic><monogr><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="pISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><idno type="DOI">10.1002/(ISSN)1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2010-05-15"></date><biblScope unit="volume">25</biblScope><biblScope unit="issue">7</biblScope><biblScope unit="page" from="932">932</biblScope><biblScope unit="page" to="936">936</biblScope></imprint></monogr><idno type="istex">65FE60C80A7EB6F121035CB743F3C053D84C4910</idno><idno type="DOI">10.1002/mds.23070</idno><idno type="ArticleID">MDS23070</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2010</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>A large community‐based cross‐sectional survey provided an opportunity to evaluate a previously reported association between Parkinson's disease (PD) and low serum uric acid (UA) levels in this population. The association between a self‐reported PD diagnosis with treatment (n = 59) and serum UA level was examined using logistic and linear regression models, controlling for key covariates. In adjusted models, participants with UA levels at or above the median had a significantly lower odds of reporting PD with treatment compared with those with lower UA levels (OR 0.33, 95% CI 0.19–0.60, P = 0.0002). This association was observed for both men and women. The mean UA level among participants reporting PD with treatment was 0.78 mg/dl lower than the mean UA level among those not reporting PD (P ≤ 0.0001). These findings concur with several previous longitudinal studies that found an association between higher UA levels and decreased PD risk. © 2010 Movement Disorder Society</p></abstract><textClass xml:lang="en"><keywords scheme="keyword"><list><head>Keywords</head><item><term>uric acid</term></item><item><term>Parkinson's disease</term></item><item><term>cross‐sectional survey</term></item></list></keywords></textClass><textClass><keywords scheme="Journal Subject"><list><head>article category</head><item><term>Brief Report</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="2009-09-03">Received</change><change when="2010-02-08">Registration</change><change when="2010-05-15">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><original>false</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/65FE60C80A7EB6F121035CB743F3C053D84C4910/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName><publisherLoc>Hoboken</publisherLoc></publisherInfo><doi registered="yes">10.1002/(ISSN)1531-8257</doi><issn type="print">0885-3185</issn><issn type="electronic">1531-8257</issn><idGroup><id type="product" value="MDS"></id></idGroup><titleGroup><title type="main" xml:lang="en" sort="MOVEMENT DISORDERS">Movement Disorders</title><title type="short">Mov. Disord.</title></titleGroup></publicationMeta><publicationMeta level="part" position="70"><doi origin="wiley" registered="yes">10.1002/mds.v25:7</doi><numberingGroup><numbering type="journalVolume" number="25">25</numbering><numbering type="journalIssue">7</numbering></numberingGroup><coverDate startDate="2010-05-15">15 May 2010</coverDate></publicationMeta><publicationMeta level="unit" type="article" position="180" status="forIssue"><doi origin="wiley" registered="yes">10.1002/mds.23070</doi><idGroup><id type="unit" value="MDS23070"></id></idGroup><countGroup><count type="pageTotal" number="5"></count></countGroup><titleGroup><title type="articleCategory">Brief Report</title><title type="tocHeading1">Brief Reports</title></titleGroup><copyright ownership="thirdParty">Copyright © 2010 Movement Disorder Society</copyright><eventGroup><event type="manuscriptReceived" date="2009-09-03"></event><event type="manuscriptRevised" date="2009-11-30"></event><event type="manuscriptAccepted" date="2010-02-08"></event><event type="firstOnline" date="2010-03-22"></event><event type="publishedOnlineFinalForm" date="2010-05-05"></event><event type="publishedOnlineAcceptedOrEarlyUnpaginated" date="2010-03-22"></event><event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.5.2 mode:FullText" date="2011-08-12"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-02"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-31"></event></eventGroup><numberingGroup><numbering type="pageFirst">932</numbering><numbering type="pageLast">936</numbering></numberingGroup><correspondenceTo>Rollins School of Public Health, 1518 Clifton Road NE, Room 214, Atlanta, GA 30322</correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:MDS.MDS23070.pdf"></link></linkGroup></publicationMeta><contentMeta><countGroup><count type="figureTotal" number="0"></count><count type="tableTotal" number="2"></count><count type="referenceTotal" number="14"></count><count type="wordTotal" number="4623"></count></countGroup><titleGroup><title type="main" xml:lang="en">Higher serum uric acid associated with decreased Parkinson's disease prevalence in a large community‐based survey<link href="#fn5"></link></title><title type="short" xml:lang="en">Uric Acid and Parkinson's Disease Prevalence</title></titleGroup><creators><creator xml:id="au1" creatorRole="author" affiliationRef="#af1" corresponding="yes"><personName><givenNames>Andrea</givenNames><familyName>Winquist</familyName><degrees>MD, PhD</degrees></personName><contactDetails><email>awinqui@sph.emory.edu</email></contactDetails></creator><creator xml:id="au2" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Kyle</givenNames><familyName>Steenland</familyName><degrees>PhD</degrees></personName></creator><creator xml:id="au3" creatorRole="author" affiliationRef="#af2"><personName><givenNames>Anoop</givenNames><familyName>Shankar</familyName><degrees>MD, PhD</degrees></personName></creator></creators><affiliationGroup><affiliation xml:id="af1" countryCode="US" type="organization"><unparsedAffiliation>Department of Environmental and Occupational Health, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA</unparsedAffiliation></affiliation><affiliation xml:id="af2" countryCode="US" type="organization"><unparsedAffiliation>Department of Community Medicine, West Virginia University School of Medicine, Morgantown, West Virginia, USA</unparsedAffiliation></affiliation></affiliationGroup><keywordGroup xml:lang="en" type="author"><keyword xml:id="kwd1">uric acid</keyword><keyword xml:id="kwd2">Parkinson's disease</keyword><keyword xml:id="kwd3">cross‐sectional survey</keyword></keywordGroup><fundingInfo><fundingAgency>C8 Class Action Settlement Agreement (Circuit Court of Wood County, West Virginia)</fundingAgency></fundingInfo><abstractGroup><abstract type="main" xml:lang="en"><title type="main">Abstract</title><p>A large community‐based cross‐sectional survey provided an opportunity to evaluate a previously reported association between Parkinson's disease (PD) and low serum uric acid (UA) levels in this population. The association between a self‐reported PD diagnosis with treatment (n = 59) and serum UA level was examined using logistic and linear regression models, controlling for key covariates. In adjusted models, participants with UA levels at or above the median had a significantly lower odds of reporting PD with treatment compared with those with lower UA levels (OR 0.33, 95% CI 0.19–0.60, <i>P</i> = 0.0002). This association was observed for both men and women. The mean UA level among participants reporting PD with treatment was 0.78 mg/dl lower than the mean UA level among those not reporting PD (<i>P</i> ≤ 0.0001). These findings concur with several previous longitudinal studies that found an association between higher UA levels and decreased PD risk. © 2010 Movement Disorder Society</p></abstract></abstractGroup></contentMeta><noteGroup><note xml:id="fn5"><p>Potential conflict of interest: None reported.</p></note></noteGroup></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Higher serum uric acid associated with decreased Parkinson's disease prevalence in a large community‐based survey</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>Uric Acid and Parkinson's Disease Prevalence</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Higher serum uric acid associated with decreased Parkinson's disease prevalence in a large community‐based survey</title></titleInfo><name type="personal"><namePart type="given">Andrea</namePart><namePart type="family">Winquist</namePart><namePart type="termsOfAddress">MD, PhD</namePart><affiliation>Department of Environmental and Occupational Health, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA</affiliation><description>Correspondence: Rollins School of Public Health, 1518 Clifton Road NE, Room 214, Atlanta, GA 30322</description><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Kyle</namePart><namePart type="family">Steenland</namePart><namePart type="termsOfAddress">PhD</namePart><affiliation>Department of Environmental and Occupational Health, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Anoop</namePart><namePart type="family">Shankar</namePart><namePart type="termsOfAddress">MD, PhD</namePart><affiliation>Department of Community Medicine, West Virginia University School of Medicine, Morgantown, West Virginia, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="article" displayLabel="article"></genre><originInfo><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><place><placeTerm type="text">Hoboken</placeTerm></place><dateIssued encoding="w3cdtf">2010-05-15</dateIssued><dateCaptured encoding="w3cdtf">2009-09-03</dateCaptured><dateValid encoding="w3cdtf">2010-02-08</dateValid><copyrightDate encoding="w3cdtf">2010</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType><extent unit="tables">2</extent><extent unit="references">14</extent><extent unit="words">4623</extent></physicalDescription><abstract lang="en">A large community‐based cross‐sectional survey provided an opportunity to evaluate a previously reported association between Parkinson's disease (PD) and low serum uric acid (UA) levels in this population. The association between a self‐reported PD diagnosis with treatment (n = 59) and serum UA level was examined using logistic and linear regression models, controlling for key covariates. In adjusted models, participants with UA levels at or above the median had a significantly lower odds of reporting PD with treatment compared with those with lower UA levels (OR 0.33, 95% CI 0.19–0.60, P = 0.0002). This association was observed for both men and women. The mean UA level among participants reporting PD with treatment was 0.78 mg/dl lower than the mean UA level among those not reporting PD (P ≤ 0.0001). These findings concur with several previous longitudinal studies that found an association between higher UA levels and decreased PD risk. © 2010 Movement Disorder Society</abstract><note type="content">*Potential conflict of interest: None reported.</note><note type="funding">C8 Class Action Settlement Agreement (Circuit Court of Wood County, West Virginia)</note><subject lang="en"><genre>Keywords</genre><topic>uric acid</topic><topic>Parkinson's disease</topic><topic>cross‐sectional survey</topic></subject><relatedItem type="host"><titleInfo><title>Movement Disorders</title></titleInfo><titleInfo type="abbreviated"><title>Mov. Disord.</title></titleInfo><genre type="Journal">journal</genre><subject><genre>article category</genre><topic>Brief Report</topic></subject><identifier type="ISSN">0885-3185</identifier><identifier type="eISSN">1531-8257</identifier><identifier type="DOI">10.1002/(ISSN)1531-8257</identifier><identifier type="PublisherID">MDS</identifier><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>25</number></detail><detail type="issue"><caption>no.</caption><number>7</number></detail><extent unit="pages"><start>932</start><end>936</end><total>5</total></extent></part></relatedItem><identifier type="istex">65FE60C80A7EB6F121035CB743F3C053D84C4910</identifier><identifier type="DOI">10.1002/mds.23070</identifier><identifier type="ArticleID">MDS23070</identifier><accessCondition type="use and reproduction" contentType="copyright">Copyright © 2010 Movement Disorder Society</accessCondition><recordInfo><recordContentSource>WILEY</recordContentSource><recordOrigin>Wiley Subscription Services, Inc., A Wiley Company</recordOrigin></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002639 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 002639 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= ISTEX:65FE60C80A7EB6F121035CB743F3C053D84C4910
|texte= Higher serum uric acid associated with decreased Parkinson's disease prevalence in a large community‐based survey
}}
| This area was generated with Dilib version V0.6.23. |  |